Aderans Research Institute   Report issue

For profit Phase 2
Founded: Tokyo Japan (1968)
Status: No NME R&D (1968)

Organization Overview

First Clinical Trial
2008
NCT01451021
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2012

Timeline

NOW
  • Now